DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,225 | +3.4% | 13 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $3,120 | -93.4% | 13 | -93.1% | 0.00% | -94.4% |
| Q1 2023 | $47,384 | -5.0% | 188 | 0.0% | 0.02% | -5.3% |
| Q4 2022 | $49,899 | -99.9% | 188 | 0.0% | 0.02% | -5.0% |
| Q3 2022 | $48,559,000 | +6.4% | 188 | +4.4% | 0.02% | +11.1% |
| Q2 2022 | $45,634,000 | -12.9% | 180 | 0.0% | 0.02% | -5.3% |
| Q1 2022 | $52,402,000 | -11.5% | 180 | 0.0% | 0.02% | -5.0% |
| Q4 2021 | $59,222,000 | +11.2% | 180 | +2.9% | 0.02% | 0.0% |
| Q3 2021 | $53,277,000 | +13.4% | 175 | 0.0% | 0.02% | +5.3% |
| Q2 2021 | $46,963,000 | +19.2% | 175 | 0.0% | 0.02% | +18.8% |
| Q1 2021 | $39,389,000 | +1.3% | 175 | 0.0% | 0.02% | -11.1% |
| Q4 2020 | $38,875,000 | +3.2% | 175 | 0.0% | 0.02% | -10.0% |
| Q3 2020 | $37,683,000 | +21.8% | 175 | 0.0% | 0.02% | +17.6% |
| Q2 2020 | $30,945,000 | +128837.5% | 175 | 0.0% | 0.02% | +6.2% |
| Q1 2020 | $24,000 | -11.1% | 175 | 0.0% | 0.02% | +14.3% |
| Q4 2019 | $27,000 | – | 175 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |